Located in the vibrant city of Hyderabad, India, Waterley Pharmaceuticals is an industry-leading pharmaceutical company. Our exceptional team of dynamic professionals brings together a wealth of experience garnered over many years in the pharmaceutical field.
Recognizing the urgent demand for innovative medical solutions, we are committed to making a positive impact on the lives of millions of individuals. Our primary focus lies in advancing gastro-intestinal therapy, catering to the specific needs of patients in this area.
At Waterley Pharmaceuticals, our ultimate objective is to improve the well-being of people globally by providing effective and groundbreaking pharmaceutical treatments.
Gastrointestinal diseases in Asian populations have been a major health issue during the past two decades. The incidence and prevalence rates have shown a notable rise, with the consequence that GI diseases are increasingly the cause of morbidity and mortality in Asian countries.
In the present scenario, while diseases like diarrhoeas, hepatitis, typhoid, TB of the intestinal tract etc. are still prevalent, there is an alarming is the rise of lifestyle diseases like Irritable Bowel syndrome (IBS), Gastroesophageal reflux disease (GERD), inflammatory bowel disease like Crohn’s and non-alcoholic fatty liver and cancers of the food pipe, colon and liver, pancreas and gallbladder.
Waterley Pharmaceuticals sees opportunities in this growing gastrointestinal therapy segment in India and neighbouring Asian countries. The company markets innovative, high quality medications to meet the evolving challenges and unmet needs of patients.